medicalxpress.com
Recent research highlights the intensified cognitive decline and increased mortality risk among dementia patients with rheumatoid arthritis, emphasizing the need for tailored management strategies.
The significant impact of rheumatoid arthritis (RA) on cognitive deterioration among patients with dementia has been brought to light through recent findings from a Swedish study. This research, led by experts at Karolinska Institutet, underscores the necessity of revising current healthcare practices to better accommodate the overlapping effects of these two conditions.
"Our results show that RA is associated with poorer cognitive outcomes in dementia patients, especially those with Alzheimer's disease or mixed Alzheimer's dementia," says Minjia Mo.
The study included a cohort of 1,685 individuals diagnosed with both dementia and RA, revealing a notable acceleration in the decline of cognitive function—measured at β = −0.24 points per year among those affected by RA. Additionally, the hazard ratio for mortality in this group stood at 1.15, indicating a heightened risk compared to dementia patients without RA.
Implications for Clinical Practice
The dual challenge posed by RA in dementia patients calls for a comprehensive approach to clinical care. Healthcare providers are urged to rethink their strategies by integrating regular monitoring of inflammatory markers and considering the inclusion of anti-inflammatory therapies. Such an interdisciplinary approach could potentially slow the rate of cognitive decline observed in these patients.
"We plan to continue our research to understand how systemic inflammation in RA contributes to neuroinflammation and cognitive decline," says Hong Xu.
This evolving understanding compels clinicians to adopt more holistic treatment protocols. The ongoing discourse by the Karolinska Institutet indicates that mitigating systemic inflammation could be key in preserving cognitive function among those suffering from RA-associated complications.
Given these insights, the incorporation of interdisciplinary care strategies holds promise not only for managing cognitive symptoms but also potentially extending the quality lifespan of affected individuals.